Società Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE
Azioni
IL0010810096
Prodotti farmaceutici
Attività
Vendite per attività
ILS in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Core Products
64,8
%
| 161 | 60,9 % | 190 | 64,8 % | +17,90% |
Distribution Special
29,8
%
| 88 | 33,5 % | 87 | 29,8 % | -1,33% |
Other
5,4
%
| 15 | 5,6 % | 16 | 5,4 % | +5,64% |
Vendite per regione
ILS in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 264 | 100,0 % | 292 | 100,0 % | +10,78% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 80 | 24/08/93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 01/11/18 |
Director/Board Member | 78 | 24/08/93 | |
Jack Azran
PRN | Corporate Officer/Principal | - | - |
Guy Zangi
SAM | Sales & Marketing | 51 | 13/09/18 |
Yuval Elgrably
PRN | Corporate Officer/Principal | 47 | 31/03/11 |
Ronit Zelnik
PRN | Corporate Officer/Principal | 66 | 09/01/97 |
Joseph Ginossar
AUD | Comptroller/Controller/Auditor | 65 | 15/06/14 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15/04/15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15/04/15 |
Avraham Bigger
CHM | Chairman | 77 | 15/04/15 |
Chief Executive Officer | 80 | 24/08/93 | |
Director/Board Member | 78 | 24/08/93 | |
Orly Silberman
BRD | Director/Board Member | 64 | 15/04/15 |
Udi Nissan Nisan
BRD | Director/Board Member | 55 | 01/11/16 |
Arnon Zuaretz
BRD | Director/Board Member | 70 | 01/11/16 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 11 523 922 | 2 000 627 ( 17,36 %) | 19 900 ( 0,1727 %) | 17,36 % |
Coordinate società
Settore
Vendite per attività
Variaz. 1 gen. | Capi. | |
---|---|---|
+21,82% | 73,38 Mrd | |
-2,32% | 24,13 Mrd | |
+4,89% | 8,78 Mrd | |
+10,52% | 8,59 Mrd | |
-19,56% | 8,06 Mrd | |
+14,16% | 5,26 Mrd | |
-0,93% | 4,21 Mrd | |
+12,13% | 4,17 Mrd | |
-2,54% | 3,89 Mrd |